Apo-Brimonidine-Timop 0.5 % (Timolol (Timolol Maleate) SOLUTION) 0.5 %

APO-BRIMONIDINE-TIMOP 0.5% is an ophthalmic solution combining brimonidine and timolol for eye care. It is used to manage certain eye conditions, including intraocular pressure. This medication is suitable for those seeking effective eye treatment options.

Strength

0.5 %

Pack Size

5ML/10ML

Manufacturer / TM Owner

APOTEX INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

APO-BRIMONIDINE-TIMOP 0.5% is primarily used for managing intraocular pressure in the eyes. This ophthalmic solution is often prescribed to help reduce pressure and support overall eye health. It is designed for those who need a reliable treatment for eye-related conditions.

Side Effects

Common effects of APO-BRIMONIDINE-TIMOP 0.5% may include temporary eye irritation, redness, or blurred vision. Some users might experience mild discomfort or itching. These effects are generally short-lived and should subside as the eyes adjust to the medication.

Precautions & Warnings

Handle APO-BRIMONIDINE-TIMOP 0.5% with care, ensuring it is kept out of reach of children. Avoid touching the tip of the dropper to prevent contamination. If you experience persistent discomfort or severe side effects, consult a healthcare professional.

Avoid Interactions

APO-BRIONIDINE-TIMOP 0.5% may interact with other medications, including certain eye drops or oral medications. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always follow the prescribed usage guidelines.

Frequently Asked Questions

APO-BRIMONIDINE-TIMOP 0.5% is used to manage intraocular pressure in the eyes, often prescribed for conditions related to eye health.

Store APO-BRIMONIDINE-TIMOP 0.5% at room temperature, away from direct sunlight and out of reach of children.

Consult your healthcare provider before using APO-BRIMONIDINE-TIMOP 0.5% with other eye drops to avoid potential interactions.

Common side effects may include temporary eye irritation, redness, or blurred vision. These effects are usually mild and short-lived.

Long-term use should be monitored by a healthcare professional to ensure continued safety and effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.